AbbVie Inc.·4

Mar 3, 6:10 PM ET

Purdue David Ryan 4

4 · AbbVie Inc. · Filed Mar 3, 2026

Research Summary

AI-generated summary of this filing

Updated

AbbVie (ABBV) SVP/Controller David Ryan Purdue Sells 2,692 Shares

What Happened

  • David Ryan Purdue, SVP and Controller of AbbVie, had 2,692 shares disposed on February 27, 2026 to satisfy a tax payment/withholding obligation (transaction code F). The shares were recorded at $232.08 per share for a total value of $624,759. This is a routine tax-withholding disposition, not a discretionary open-market sale.

Key Details

  • Transaction date: 2026-02-27; Filing date (Form 4): 2026-03-03 (timely filed).
  • Price: $232.08 per share; Shares disposed: 2,692; Total value: $624,759.
  • Transaction code: F — payment of exercise price or tax liability (shares were withheld/sold to cover taxes).
  • Shares owned after the transaction: not specified in the provided filing excerpt.
  • Footnote: F1 notes the shares came from the AbbVie Savings program balance as of Feb 20, 2026, which includes shares acquired via dividend reinvestment.

Context

  • This appears to be a tax-withholding/cashless-type disposition tied to an equity event (e.g., option exercise or award vesting). Such withholdings are routine and do not necessarily indicate a change in the insider’s view of the company.

Insider Transaction Report

Form 4
Period: 2026-02-27
Purdue David Ryan
SVP, Controller
Transactions
  • Tax Payment

    Common Stock, $0.01 par value

    2026-02-27$232.08/sh2,692$624,7597,884 total
Holdings
  • Common Stock, $0.01 par value

    [F1]
    (indirect: By Trust)
    543
Footnotes (1)
  • [F1]Balance in AbbVie Savings program as of February 20, 2026. Balance includes shares acquired pursuant to a dividend reinvestment feature.
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for David R. Purdue|2026-03-03

Documents

1 file
  • 4
    form4-03032026_060303.xmlPrimary